广济药业 (000952)

HUBEI GUANGJI PHARMACEUTICAL CO., LTD

ASZ

Tags

Pharmaceutical ManufacturingSynthetic BiologySmall Cap State-Owned EnterprisesMicro Cap StocksDecreasing Shareholder CountVitaminsHepatitis Concept

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 34675.03
  • Circulating A-Shares(W): 34399.60
  • Earnings Per Share(RMB): -0.2789
  • Net Assets Per Share(RMB): 2.7842
  • Operating Revenue(W RMB): 42926.37
  • Total Profit(W RMB): -10698.58
  • Net Profit Attributable to Parent(W RMB): -9729.86
  • Net Profit Growth Rate(%): 38.64
  • Weighted Return on Equity(%): -9.5400
  • Operating Cash Flow Per Share(RMB): 0.1370
  • Undistributed Profit Per Share(RMB): 0.3175
  • Capital Reserve Per Share(RMB): 1.0538

2. Main Business

The main business covers:

  • Research, development, production, and sales of vitamin raw materials.

3. Company Basic Information

  • Company Name: Hubei Guangji Pharmaceutical Co., Ltd.
  • Listing Date: 1999-11-12
  • Industry: Pharmaceutical Manufacturing
  • Address: No.1 Jiangdi Road, Wuxue City, Hubei Province
  • Website: www.guangjipharm.com
  • Company Profile：The company's predecessor was Hubei Guangji Pharmaceutical Factory. After approval, it was restructured from Hubei Guangji Pharmaceutical Factory and jointly initiated with Hubei Huichun Pharmaceutical Factory and Wuxue Caizhen Accounting Industrial Company. It was established as a joint-stock company by private placement on May 28, 1999. After issuing 50 million public shares (including 5 million shares allocated to investors) on August 20, 1999, the company's total share capital reached 171.226 million shares. Its 45 million public shares were listed and traded on the Shenzhen Stock Exchange on November 12, 1999.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Changjiang Industrial Investment Group Co., Ltd. General Legal Person 8759.21 25.46
2 Wuhan Torch Venture Capital Co., Ltd. General Legal Person 1485.50 4.32
3 MORGAN STANLEY & CO.INTERNATIONAL PLC. QFII 298.59 0.87
4 ChinaAMC CSI 500 Index Enhanced Securities Investment Fund A Fund 228.14 0.66
5 Jinyuan Shun'an Yuanqi Flexible Allocation Hybrid Securities Investment Fund Fund 204.77 0.60
6 Bohai Huijin New Momentum Theme Hybrid Securities Investment Fund A Fund 14.68 0.04
7
8
9
10

5. Concept Sectors

  • Vitamins
  • Hepatitis Concept
  • Synthetic Biology
  • Micro-cap Stocks
  • Consecutive Losses
  • Decreasing Shareholder Numbers
  • Recent Weakness
  • Small-cap State-owned Enterprise

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information